Cargando…
Transcatheter arterial chemoembolization is safe and effective for patients with late-stage or recurrent oral carcinoma
OBJECTIVE: We reported the long-term outcomes of transcatheter chemoembolization (TACE) for patients with late-stage or recurrent oral carcinoma. METHODS: This retrospective study enrolled 18 patients with late-stage or recurrent oral carcinoma between December 2015 and April 2021. The tumor-feeding...
Autores principales: | Bi, Yonghua, Du, Tianfeng, Pan, Wenting, Tang, Fan, Wang, Yang, Jiao, Dechao, Han, Xinwei, Ren, Jianzhuang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353522/ https://www.ncbi.nlm.nih.gov/pubmed/35936680 http://dx.doi.org/10.3389/fonc.2022.831583 |
Ejemplares similares
-
Clinical Outcomes of Drug-Eluting Bead Transarterial Chemoembolization Loaded with Raltitrexed for the Treatment of Unresectable or Recurrent Hepatocellular Carcinoma
por: Bi, Yonghua, et al.
Publicado: (2022) -
Preliminary outcomes of raltitrexed eluting bead-transarterial chemoembolization using Callispheres® beads for gastrointestinal adenocarcinoma liver metastasis
por: Bi, Yonghua, et al.
Publicado: (2022) -
Safety and efficacy of iodine-125 seed strand for intraluminal brachytherapy on ureteral carcinoma
por: Bi, Yonghua, et al.
Publicado: (2023) -
Correlation between magnetic resonance images of peritumor margin enhancement and prognosis in hepatocellular carcinoma after drug-eluting bead transcatheter arterial chemoembolization
por: Kuang, Donglin, et al.
Publicado: (2023) -
Clinical outcomes of doxorubicin-eluting CalliSpheres beads-transarterial chemoembolization for unresectable or recurrent esophageal carcinoma
por: Bi, Yonghua, et al.
Publicado: (2021)